In accordance with LR 9.6, the Board of Albion Technology & General VCT PLC announced that Mary Anne Cordeiro is retiring from the Company with effect from 18 May 2023. It was announced earlier, that Mary Anne, has been appointed to the board of Seneca Growth Capital VCT PLC, a venture capital trust. Mary Anne served on the Board of Albion Income and Growth VCT PLC from July 2004 until its merger with the Company in November 2013.

She was then appointed to the Board of the Company on 18 November 2013 and was also the Senior Independent Director and chaired the Remuneration Committee. As part of Board succession planning, Mary Anne was due to stand down having served for more than nine years for the Company. Margaret Payn, the Company’s Audit & Risk Chair, will succeed her as the Senior Independent Director.

Mary Anne brings to the Board extensive knowledge of both the VCT and growth capital investment sectors, having been an advisor to or executive of innovative companies in the healthcare and technology sectors for over twenty years. Mary Anne has served as a non-executive Director of Albion Technology & General VCT Plc (“AATG”) from 2013 until 2023, following its merger with Albion Income & Growth VCT Plc where she had served as a non-executive Director from 2004. Having served nine years as non-executive Director, more recently as Senior Independent Director and Chair of the Remuneration Committee, Mary Anne is retiring from the AATG Board today.

Mary Anne is also the Founder and Managing Director of Science to Business Limited which specialises in advising medical technology businesses on fundraising and commercialisation strategy. Prior to this Mary Anne had a fifteen-year career in international corporate finance as a M&A Investment Banker at Goldman Sachs International Limited, Vice President at Bankers Trust Company and Managing Director of Paribas’ Financial Institutions Group. Mary Anne holds a MA (Hons) in Chemistry from the University of Oxford and is a member of the University of Oxford’s Department of Chemistry Development Board.

Mary Anne will stand for election at the Annual General Meeting of the Company to be held in 2024. There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Mary Anne. Company also announced that further to Richard Roth’s retirement from the Board, with effect from Annual General Meeting, Alex Clarkson has been appointed as Chair of the Audit Committee.

Alex qualified as a Chartered Accountant with PwC in 1998 and has served as an independent non-executive Director of the Company and been a member of the Audit Committee since 2019.